Biocorrx Inc New (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 577 | 2 | 11 | 284 | 845 |
| Receivables | 36 | 24 | 30 | 19 | 52 |
| TOTAL | $614 | $32 | $55 | $316 | $904 |
| Non-Current Assets | |||||
| PPE Net | 46 | 18 | 19 | 18 | 19 |
| Investments And Advances | 13 | 13 | 13 | 18 | 18 |
| Intangibles | 250 | 250 | 252 | 259 | 266 |
| Other Non-Current Assets | 0 | 0 | 0 | 50 | 50 |
| TOTAL | $309 | $281 | $284 | $344 | $353 |
| Total Assets | $923 | $313 | $339 | $660 | $1,256 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,225 | 1,296 | 1,215 | 706 | 618 |
| TOTAL | $4,649 | $1,953 | $1,639 | $1,143 | $1,106 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 2,383 | 2,016 | 1,641 | 1,266 |
| Deferred Revenues | 237 | 237 | 237 | 251 | 302 |
| Other Non-Current Liabilities | 0 | 0 | 176 | 86 | 111 |
| TOTAL | $284 | $2,726 | $2,593 | $2,143 | $1,844 |
| Total Liabilities | $4,933 | $4,679 | $4,232 | $3,286 | $2,950 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,472 | 2,471 | 2,466 | 2,432 | 2,421 |
| Common Shares | 1,497 | 347 | 102 | 343 | 342 |
| Retained earnings | -50,888 | -49,666 | -48,841 | -47,269 | -46,167 |
| TOTAL | $-4,010 | $-4,366 | $-3,893 | $-2,626 | $-1,694 |
| Total Liabilities And Equity | $923 | $313 | $339 | $660 | $1,256 |